K211120 is an FDA 510(k) clearance for the ERIC Retrieval Device. Classified as Catheter, Thrombus Retriever (product code NRY), Class II - Special Controls.
Submitted by MicroVention, Inc. (Aliso Viejo, US). The FDA issued a Cleared decision on March 31, 2022 after a review of 350 days - an unusually long review period, suggesting complex equivalence evaluation.
This device falls under the Neurology FDA review panel, regulated under 21 CFR 870.1250 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.
NCT03776877
Unknown
Observational
Endovascular Treatment in Ischemic Stroke Follow-up Evaluation
Evaluation of Clinical and Imaging Criteria, and Plasma Biomarkers of Patients Receiving an Endovascular Treatment for an Acute Ischemic Stroke
| Condition studied |
Stroke, Acute |
| Eligibility |
All sexes
· 18 Years+
|
| Principal investigator |
Bertrand Larpergue, MD |
| Sponsor |
Hopital Foch
|
Started 2018-06-26
→
Primary completion 2022-12-01
Primary outcome
Clinical outcome
Secondary outcome
Efficacy on reperfusion (modified Thrombolysis in Cerebral Infarction (mTICI) 2b/3)
View full study on ClinicalTrials.gov